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who received active treatment lived longer than those who received 
the best supportive care (NSCLC: 12 vs. 4 months, p=0.015, Figure 1; 
SCLC: 14 vs. 5 months, p=0.02, Figure 2).
There was a similar response to chemotherapy between the elderly and 
non-elderly patients (NSCLC: p=0.386; SCLC: p=0.172). 
Conclusion: Even though elderly patients have a poor performance 
status compared with non elderly patients, chemotherapy improves the 
overall survival time and response rate in eligible patients. 
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Introduction: We frequently encounter patients with lung cancer who 
have impaired lung function and co-morbidity that place them at high 
risk for surgery. Signiﬁcant toxicity arising from stereotatic body radia-
tion therapy for central airway cancers was recently been reported. 
Aim: To determine efﬁcacy of bronchoscopic treatment (BT) for early 
intraluminal squamous cell cancers (ISCC) in patients unﬁt for surgery. 
Methods: Patients suspected of lung cancer underwent autoﬂuores-
cence bronchoscopy (AF) and data on demographics, smoking, pack 
years, comorbidity, therapy, and outcome were prospectively collected 
and entered into database since 1996. 
Results: There were 60 current and former smokers of 40 pack years 
(range, 32-50), 47 males, with median age 69 years (range, 64-75). 
Forty seven patients (78%) had moderate to very severe COPD and 19 
(32%) with coronary heart disease. All had early ICSS conﬁned within 
the airway wall deﬁned initially by high resolution CT at 1 mm, and 
subsequently by multidetector CT at 0.75 mm slices. As they were all 
considered non-resectable or marginally resectable surgical candidates, 
29 satisﬁed the criteria of radiographically occult cancers with visible 
tumor margins and size ≤1cm2 whilst the other 31 patients who were 
matched in age and comorbidity, had tumor margins that extended be-
yond visibility of AF. All underwent BT with endobronchial electrosur-
gery or cryotherapy. Median follow up was 40 months (range, 21-73), 
and no toxicity or death related to BT was observed. Lung cancer 
related mortality was 18%. Kaplan-Meier survival of both groups are 
shown (p=0.19).
Conclusion: BT is a safe alternative for patients with centrally located 
early ISCC who are precluded from or at risk for curative surgery due 
to their signiﬁcant comorbidity.
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Background: Most of patients (pts) with lung cancer are not candi-
dates for curative surgery at time of diagnosis. Aims of our study were 
to describe the recent situation with diagnostics and therapeutical 
modalities and to look for reasons of low operability of lung cancer in 
the Czech Republic.
Methods: A retrospective study on 272 consecutive lung cancer pts. A 
special attention was paid to the relation between smoking status and 
the onset of lung cancer, to the coincidence with COPD and correlation 
of bronchoscopic ﬁndings with other pts characteristics. 
Results: 184 men and 88 women (ratio 2:1) were studied. There were 
60 % of recent smokers, 24 % of ex-smokers and 16 % of never smok-
ers. Lung cancer was diagnosed in signiﬁcantly earlier age in smokers 
(median age men 65, women 61 years) than in ex-smokers (median age 
men and women 73 years). Men smoked statistically more cigarettes 
